Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
January 03 2017 - 9:00AM
PR Newswire (US)
BOULDER, Colo., Jan. 3, 2017 /PRNewswire/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer,
Ron Squarer, will speak at the
Annual J.P. Morgan Healthcare Conference in San Francisco.
The public is welcome to participate in the conference through a
webcast on the Array BioPharma website.
|
Event:
|
Annual J.P. Morgan
Healthcare Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer, Array BioPharma
|
|
Date:
|
Wednesday, January
11, 2017
|
|
Time:
|
8:30 a.m. Pacific
Time
|
|
Location:
|
Westin St. Francis
Hotel, San Francisco
|
|
Webcast:
|
http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22698
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Five registration studies are
currently advancing related to three cancer drugs. These programs
include binimetinib (MEK162), encorafenib (LGX818) and selumetinib
(AstraZeneca).
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300377960.html
SOURCE Array BioPharma
Copyright 2017 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
